Literature DB >> 20962577

Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology.

Nektarios Barabutis1, Andrew V Schally.   

Abstract

Growth Hormone-Releasing Hormone (GHRH) is secreted by the hypothalamus and regulates the release of growth hormone from the anterior pituitary gland. In addition to its endocrine role, this peptide has been shown to act as a growth factor in diverse malignancies. Recent studies indicate that GHRH is also a regulator of several important physiological processes. These processes which include the regulation of the metabolism of the reactive oxygen and nitrogen species are similarly enhanced by GHRH agonists. In contrast, GHRH antagonists can counteract the growth factor effects of GHRH. GHRH and its agonists have been shown to contribute to the recovery of heart tissue after myocardial infarction and can promote the survival and proliferation of pancreatic islets after transplantation into diabetic animals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962577     DOI: 10.4161/cc.9.20.13787

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

1.  Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Authors:  Ferenc G Rick; Andrew V Schally; Luca Szalontay; Norman L Block; Karoly Szepeshazi; Mehrdad Nadji; Marta Zarandi; Florian Hohla; Stefan Buchholz; Stephan Seitz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-18       Impact factor: 11.205

2.  Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.

Authors:  Nikolina Dioufa; Elena Farmaki; Andrew V Schally; Hippokratis Kiaris; Dimitris Vlahodimitropoulos; Athanasios G Papavassiliou; Christos Kittas; Norman L Block; Ioulia Chatzistamou
Journal:  Horm Cancer       Date:  2012-03-23       Impact factor: 3.869

3.  P53 supports endothelial barrier function via APE1/Ref1 suppression.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Agnieszka Siejka; John D Catravas; Nektarios Barabutis
Journal:  Immunobiology       Date:  2019-04-18       Impact factor: 3.144

4.  Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.

Authors:  Victoria Florea; Sonia S Majid; Rosemeire M Kanashiro-Takeuchi; Ren-Zhi Cai; Norman L Block; Andrew V Schally; Joshua M Hare; Claudia O Rodrigues
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

5.  GHRH antagonists support lung endothelial barrier function.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Sitanshu S Singh; Khadeja-Tul Kubra; Andrew V Schally; Seetharama Jois; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2019-10-03

Review 6.  P53 versus inflammation: an update.

Authors:  Khadeja-Tul Kubra; Mohammad S Akhter; Mohammad A Uddin; Nektarios Barabutis
Journal:  Cell Cycle       Date:  2019-12-27       Impact factor: 4.534

7.  GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.

Authors:  Ferenc G Rick; Stephan Seitz; Andrew V Schally; Luca Szalontay; Awtar Krishan; Christian Datz; Andreas Stadlmayr; Stefan Buchholz; Norman L Block; Florian Hohla
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

8.  A glimpse at growth hormone-releasing hormone cosmos.

Authors:  Nektarios Barabutis
Journal:  Clin Exp Pharmacol Physiol       Date:  2020-04-25       Impact factor: 2.557

9.  Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation.

Authors:  Yong Jie Qin; Sun On Chan; Kelvin Kam Lung Chong; Benjamin Fuk Loi Li; Tsz Kin Ng; Yolanda Wong Ying Yip; Haoyu Chen; Mingzhi Zhang; Norman L Block; Herman S Cheung; Andrew V Schally; Chi Pui Pang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

10.  Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.

Authors:  Miklos Jaszberenyi; Andrew V Schally; Norman L Block; Marta Zarandi; Ren-Zhi Cai; Irving Vidaurre; Luca Szalontay; Arumugam R Jayakumar; Ferenc G Rick
Journal:  Target Oncol       Date:  2013-02-01       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.